ClinicalTrials.govpublic full text
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
leukemia, recurrent adult acute myeloid leukemia, secondary acute myeloid leukemia, adult acute minimally differentiated myeloid leukemia (m0), adult acute myeloblastic leukemia without maturation (m1), adult acute myeloblastic leukemia with maturation (m2), adult acute myelomonocytic leukemia (m4), adult acute monoblastic leukemia (m5a), adult acute monocytic leukemia (m5b), adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(16;16)(p13;q22)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 813056
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.